OII vs TDW vs CLOV

For growth investors, Clover Health Investments, Corp.

(CLOV) is the stronger pick with 40. 3% revenue growth year-over-year, versus 0. 5% for Tidewater Inc. (TDW). Oceaneering International, Inc. (OII) offers the better valuation at 10. 6x trailing P/E (20. 5x forward), making it the more compelling value choice. Analysts rate Oceaneering International, Inc. (OII) a "Hold" — based on 44 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Oceaneering International, Inc.

(OII) is the cheapest at 10. 6x versus Tidewater Inc. at 12. 3x. On forward P/E, Tidewater Inc. is actually cheaper at 19. 8x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Tidewater Inc.

(TDW) delivered a total return of +491. 3%, compared to -67. 4% for Clover Health Investments, Corp. (CLOV). Over 10 years, the gap is even starker: OII returned +16. 7% versus CLOV's -72. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Tidewater Inc.

(TDW) is the lower-risk stock at 0. 74β versus Clover Health Investments, Corp. 's 1. 22β — meaning CLOV is approximately 64% more volatile than TDW relative to the S&P 500. On balance sheet safety, Oceaneering International, Inc. (OII) carries a lower debt/equity ratio of 45% versus 48% for Tidewater Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Clover Health Investments, Corp.

(CLOV) is pulling ahead at 40. 3% versus 0. 5% for Tidewater Inc. (TDW). On earnings-per-share growth, the picture is similar: Oceaneering International, Inc. grew EPS 142. 4% year-over-year, compared to -93. 6% for Clover Health Investments, Corp.. Over a 3-year CAGR, TDW leads at 27. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Tidewater Inc.

(TDW) is the more profitable company, earning 24. 7% net margin versus -4. 4% for Clover Health Investments, Corp. — meaning it keeps 24. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TDW leads at 21. 4% versus -4. 4% for CLOV. At the gross margin level — before operating expenses — TDW leads at 30. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Tidewater Inc.

(TDW) trades at 19. 8x forward P/E versus 65. 9x for Clover Health Investments, Corp. — 46. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TDW: 43. 2% to $117. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Tidewater Inc.

(TDW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74)). Both have compounded well over 10 years (TDW: -67. 7%, CLOV: -72. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (OII (Energy) and TDW (Energy) and CLOV (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: OII is a small-cap deep-value stock; TDW is a small-cap deep-value stock; CLOV is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.